Asthma and respiratory syncytial virus. New opportunities for therapeutic intervention;Asma y virus respiratorio sincitial. Nuevas oportunidades de intervención terapéutica

Anales de Pediatria

Volumn 61, Issue 3, 2004, Pages 252-260

  Mejias A ^a   Chavez Bueno S ^a   Rios A Ma ^a   Fonseca Aten, M ^a   Gomez A Ma ^a   Jafri, H S ^a   Ramilo, O ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Airway hyperresponsiveness; Anti RSV antibodies; RSV

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; STEROID; THROMBOSPONDIN; ANTIVIRUS AGENT; MONOCLONAL ANTIBODY; PALIVIZUMAB;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHIOLITIS; BRONCHUS OBSTRUCTION; CELLULAR IMMUNITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; LOWER RESPIRATORY TRACT INFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RISK FACTOR; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION; WHEEZING; ANIMAL; CHILD; CLINICAL TRIAL; ISOLATION AND PURIFICATION; LUNG; MOUSE; PATHOLOGY; VIROLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; ASTHMA; CHILD; CLINICAL TRIALS; HUMANS; LUNG; MICE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 18044392124     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13065284     Document Type: Review

References (57)

1. Martínez FD. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J 2003;22(2 Suppl):76-82.
2. Dickens LE, Collins PL, Wertz GW. Transcriptional mapping of human respiratory syncytial virus. J Virol 1984;52:364-9.
3. Ogra PL. Respiratory syncytial virus: the virus, the disease and the immune response. Paediatr Respir Rev 2004;5(Suppl A):119-26.
4. Collins PL, Dickens LE, Buckler-White A, Olmsted RA, Spriggs MK, Camargo E, et al. Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene order. Proc Natl Acad Sci USA 1986;83:4594-8.
5. Blount RE Jr., Morris JA, Savage RE. Recovery of cytopathogenic agent from chimpanzees with coryza. Proc Soc Exp Biol Med 1956;92:544-9.
6. Psarras S, Papadopoulos NG, Johnston SL. Pathogenesis of respiratory syncytial virus bronchiolitis-related wheezing. Paediatr Respir Rev 2004;5(Suppl A):179-84.
7. Falsey AR, Cunningham CK, Barker WH, Kouides RW, Yuen JB, Menegus M, et al. Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 1995;172:389-94.
8. Dowell SF, Anderson LJ, Gary HE Jr, Erdman DD, Plouffe JF, File TM Jr, et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis 1996;174:456-62.
9. Hashem M, Hall CB. Respiratory syncytial virus in healthy adults: the cost of a cold. J Clin Virol 2003;27:14-21.
10. Hall WJ, Hall CB, Speers DM. Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies. Ann Intern Med 1978;88:203-5.
11. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999;282:1440-6.
12. Vicente D, Montes M, Cilla G, Pérez-Yarza EG, Pérez- Trallero E. Hospitalization for respiratory syncytial vinis in the paediatric population in Spain. Epidemiol Infect 2003;131:867-72.
13. Pullan CR, Hey EN. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. Br Med J (Clin Res Ed) 1982;284(6330):1665-9.
14. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000;161:1501-7.
15. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133-8.
16. Rooney JC, Williams HE. The relationship between proved viral bronchiolitis and subsequent wheezing. J Pediatr 1971;79:744-7.
17. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-28.
18. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-5.
19. Hall CB, Hall WJ, Gala CL, MaGill FB, Leddy JP. Long-term prospective study in children after respiratory syncytial virus infection. J Pediatr 1984;105:358-64.
20. Mok JY, Simpson H. Outcome for acute bronchitis, bronchiolitis, and pneumonia in infancy. Arch Dis Child 1984;59:306-9.
21. Bont L, Aalderen WM, Kimpen JL. Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis. Paediatr Respir Rev 2000;1:221-7.
22. Sommerville RG. Respiratory syncytial virus in acute exacerbations of chronic bronchitis. Lancet 1963;47:1247-8.
23. Castro J, Telleria JJ, Blanco-Quiros A. Susceptibility genes for asthma and allergy: hits and questions. J Investig Allergol Clin Immunol 2001;11:73-8.
24. Goetghebuer T, Isles K, Moore C, Thomson A, Kwiatkowski D, Hull J. Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis. Clin Exp Allergy 2004;34:801-3.
25. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000;55:1023-7.
26. Lofgren J, Ramet M, Renko M, Marttila R, Hallman M. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis 2002;185:283-9.
27. McBride JT. Pulmonary function changes in children after respiratory syncytial virus infection in infancy. J Pediatr 1999;135(2 Pt 2):28-32.
28. Pardos Martínez C LCV, González Pérez-Yarza E, Isanta Pomar C, Fuertes Fernández-Espinar J, Meriz Rubio J. Risk factors for asthma, allergy and bronchial hyperresponsiveness in children aged 6-8 years old. An Esp Pediatr 2001;55:205-12.
29. Piedimonte G. Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae. Am J Respir Crit Care Med 2001;163(3 Pt 2):S18-21.
30. Silvestri M, Sabatini F, Defilippi AC, Rossi GA. The wheezy infant-immunological and molecular considerations. Paediatr Respir Rev 2004;5(Suppl A):81-7.
31. Welliver RC, Duffy L. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr Pulmonol 1993;15:19-27.
32. Sheeran P, Jafri H, Carubelli C, Saavedra J, Johnson C, Krisher K, et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999;18:115-22.
33. Hall CB, Powell KR, MacDonald NE, Gala CL, Menegus ME, Suffin SC, et al. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 1986;315:77-81.
34. Delage G, Brochu P, Robillard L, Jasmin G, Joncas JH, Lapointe N. Giant cell pneumonia due to respiratory syncytial virus. Occurrence in severe combined immunodeficiency syndrome. Arch Pathol Lab Med 1984;108:623-5.
35. Whimbey E, Couch RB, Englund JA, et al. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin Infect Dis 1995;21:376-9.
36. Aberle JH, Aberle SW, Dworzak MN, Mandl CW, Rebhandl W, Vollnhofer G, et al. Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med 1999;160:1263-8.
37. Garofalo RP, Patti J, Hintz KA, Hill V, Ogra PL, Welliver RC. Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis 2001;184:393-9.
38. Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003;168:633-9.
39. Haeberle HA, Kuziel WA, Dieterich HJ, Casola A, Gatalica Z, Garofalo RP. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology. J Virol 2001;75:878-90.
40. Jafri HS, Chávez-Bueno S, Mejías A, Gómez AM, Ríos AM, Nassi SS, et al. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis 2004;189:1856-65.
41. Schwarze J, O'Donnell DR, Rohwedder A, Openshaw PJ. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med 2004;169:801-5.
42. Cubie HA, Duncan LA, Marshall LA, Smith NM. Detection of respiratory syncytial virus nucleic acid in archival postmortem tissue from infants. Pediatr Pathol Lab Med 1997;17:927-38.
43. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1618-23.
44. Buckingham SC, Jafri HS, Bush AJ, Carebelli CM, Sheeran P, Hardy RD, et al. A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome. J Infect Dis 2002;185:1222-8.
45. Malley R, DeVincenzo J, Ramilo O, Dennehy PH, Meissner HC, Gruber WC, et al. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis 1998;178:1555-61.
46. Malley R, Vernacchio L, Devincenzo J, Ramilo O, Dennehy PH, Meissner HC, et al. Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions. Pediatr Infect Dis J 2000;19:1-7.
47. Edell D, Khoshoo V, Ross G, Salter K. Early ribavarin treatment of bronchiolitis: Effect on long-term respiratory morbidity. Chest 2002;122:935-9.
48. Edell D, Bruce E, Hale K, Khoshoo V. Reduced long-term respiratory morbidity after treatment of respiratory syncytial virus bronchiolitis with ribavirin in previously healthy infants: A preliminary report. Pediatr Pulmonol 1998;25:154-8.
49. Wenzel SE, Gibbs RL, Lehr MV, Simoes EA. Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin. Am J Med 2002;112:627-33.
50. Kimpen JL. Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing. Respir Res 2002;3(Suppl 1):40-5.
51. Bisgaard H. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003;167:379-83.
52. Welliver RC 2nd, Hintz KH, Glori M, Welliver RC. Sr. Zileuton reduces respiratory illness and lung inflammation, during respiratory syncytial virus infection, in mice. J Infect Dis 2003;187:1773-9.
53. Mejias A, Ramilo O. Asthma and respiratory syncytial virus. Myth or reality? An Esp Pediatr 2002;57:199-204.
54. Chavez-Bueno S, Mejías A OK, Ríos AM, Fonseca-Aten M, Hatfield J, Gómez AM, Ramilo O, et al. Respiratory syncytial virus (RSV)-induced long term airway hyperresponsiveness (AHR) is associated with viral persistence detected by real time polymerase chain reaction (RLT-PCR). Pediatric Res 2004;1:335A (1908).
55. Mejías A, Chávez-Bueno S, Ríos AM, Saavedra-Lozano J, Fonseca Aten M, Hatfield J, et al. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model. Antimicrob Agents Chemother 2004;48:1811-22.
56. Tsutsumi H. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-7.
57. Carbonell-Estrany X, Quero Jiménez J. Guidelines for respiratory syncytial virus prophylaxis. An update. An Esp Pediatr 2002;56:334-6.